1. Introduction {#sec0005}
===============

Pure or predominantly signet-ring cell carcinoma of the cervix is extremely rare in the literature. In total, 18 cases of primary cervical adenocarcinoma containing signet-ring cells have been reported to date [@bib0005]. The infrequency with which it is encountered makes primary signet-ring cell carcinoma of the cervix a diagnostic challenge. Possible metastasis from any site should be excluded, as management and prognosis vary between metastatic and primary signet ring cell carcinomas of the cervix.

Herein, we report a case of primary predominantly signet ring cell carcinoma of the cervix with immunohistochemical findings and review the literature.

2. Case report {#sec0010}
==============

A 48-year-old, gravida 5, para 3 woman with post-coital vaginal bleeding during the last 3 months was seen in our hospital. Her body mass index was 24 and she had no significant medical or family history. A pelvic examination revealed a 1--2 cm cervical mass, which appeared to originate from endocervical canal. A biopsy revealed a signet ring cell-type adenocarcinoma. Laboratory studies, including cancer antigen 125 (CA-125), carcinogenic antigen (CA 19-9), cancer antigen 15--3 (CA 15-3), carcinoembriogenic antigen (CEA), and alpha-fetoprotein (AFP), were within normal limits. Magnetic resonance imaging (MRI) showed a 1.7 × 1.5-cm cervical mass with a homogeneous intensity on T1-weighted images and a heterogeneous intensity on T2-weighted images ([Fig. 1](#fig0005){ref-type="fig"}). Increased FDG uptake on the positron emission tomography (PET)/computed tomography (CT) images were found for the cervical mass (SUVmax: 13.5). A gastroscopy and colonoscopy were performed to reveal the possible primary site of the tumour, however, both did not the site. In addition, her preoperative mammogram was negative. The patient underwent a laparoscopic type-3 radical hysterectomy with bilateral salpingo--oophorectomy, pelvic lymph node dissection and paraaortic lymph node dissection with a presumed diagnosis of primary signet ring cell carcinoma of the cervix. There was no pathologic finding in the pelvic cavity or abdomen.

Macroscopically, tumour measured 25 × 18 × 13 mm in size and it was located in ecto- and endocervix. Microscopically, the tumour consisted of 70% signet ring cell type and 30% endocervical adenocarcinoma. Signet ring cells were within pools of extracellular mucin ([Fig. 2](#fig0010){ref-type="fig"}, [Fig. 3](#fig0015){ref-type="fig"}). The tumour cells had hyperchromatic, eccentrically located nuclei and large mucin filled cytoplasmic vacuoles. An immunohistochemical study of the tumour showed positivity for p16 ([Fig. 4](#fig0020){ref-type="fig"}), CDX-2, MUC1, MUC2 and MUC5AC and negativity for synaptophysin, chromogranin A and CK--20. The parametrium, pelvic and paraaortic lymph nodes were negative and no lymphovascular space invasion was observed.

The patient did not receive postoperative chemotherapy. Follow-up at 18 months after surgery showed no evidence of recurrence.

Written informed consent was obtained from the patient to publish these data.

3. Discussion {#sec0015}
=============

Previous cases of primary signet-ring cell carcinoma of the cervix are presented in [Table 1](#tbl0005){ref-type="table"}. It is essantial to distinguish a primary tumour from metastasis when there are signet ring cells in a carcinoma within cervix. The stomach, colon, breast, appendix, bladder are possible primary sites for metastasis [@bib0005]. Therefore, further evaluations for other primary sites are mandatory to exclude metastasis. In addition, an earlier report described some features in favour of a primary cervical tumour such as a history of HPV infection, the coexistence of high-grade squamous intraepithelial lesion and adenocarcinoma in situ with an invasive disease and HPV type 18 in tumour tissue [@bib0020]. In our case, a gastroscopy and colonoscopy were performed and the patient underwent MRI and PET/CT. However, no other tumour lesion was found. Our patient had a history of HPV infection, and HPV type 18 was found in her tumour tissue. HPV type 18 is a well-known risk factor for cervical adenocarcinomas. Hence, almost all of the reports searching for HPV-DNA in cases with primary signet ring cell adenocarcinoma of the cervix including ours showed HPV type 18 positivity, an association with HPV type 18 and primary signet ring cell adenocarcinoma of the cervix may be easily suggested.

Immunohistochemical studies were performed in most of the previous studies. However, conflicting results have been obtained ([Table 1](#tbl0005){ref-type="table"}). Three cases were negative for mammoglobin and no positive case was reported. Similarly, two cases reported positive reaction with p16, which may show an HPV effect on the tumour. No negative case was reported with p16 immunohistochemical staining. To date, positivity for cytokeratin 7 was shown in five cases, and it seems to be the most prominent immunohistochemical marker. In a recent study, cervical cytokeratin 7 positivity was found to be associated with progression of low grade cervical lesions to high grade cervical lesions [@bib0075]. The literature regarding immunohistochemical staining with MUC 1, MUC 2, MUC 5, chromogranin A and synaptophysin showed different results. Only one but 6 cases stained for CK 20 showed negativity. In addition, while CDX2 was shown to be negative in all of four cases that were stained, for the first time, we found positivity. This finding might be considered as unexpected, since CDX2 is specifically expressed in colorectal adenocarcinomas. Based on conflicting results, one can conclude that immunohistochemical studies are not even close to rejecting or proving the diagnosis of primary signet cell cervical cancer.

While the data on primary signet cell carcinoma of the cervix is not enough to provide a recommendation regarding treatment, we managed our patient as having an adenocarcinoma of the cervix. Because there were no intermediate (large tumour size, cervical stromal invasion to the middle or deep one-third, lymphovascular space invasion) or high risk factors (positive margins, positive lymph nodes, parametrial involvement) for recurrent disease, we did not offer any adjuvant treatment.

It is not easy to predict survival because of the small number of the cases. In two cases with stage IV, patients died of disease in 2 months [@bib0050]. However, more than 10 years disease-free survival was reported in a patient with stage IB1 disease. While our case was staged as IB1, a long-term survival may be hoped.

In conclusion, it is crucial to differantiate primary from metastatic signet cell carcinoma of the cervix. If our case had been accepted as a metastasis, it would have been stage IV and received a very different kind of therapy. A clinical examination and imaging studies should be performed carefully for this purpose. Immunohistochemical studies may be helpful, especially when the number of cases increases. In addition, HPV DNA positivity may confirm the diagnosis as primary.
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![(A) 1.7 × 1.5-cm cervical mass with a homogeneous intensity on T1-weighted images and a heterogeneous intensity on T2-weighted images on posterior cervix.](gr1){#fig0005}

![The tumor was located in ecto-endocervix. HE X50.](gr2){#fig0010}

![The tumor was composed of signet ring cells within pools of extracellular mucin. HE ×200.](gr3){#fig0015}

![The nuclei of tumor cells were diffusely positive for p16. p16 ×400.](gr4){#fig0020}

###### 

Summary of cases of primary signet-ring cell carcinoma of the cervix, modified from Giordano et al. [@bib0070].

  --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Author, year               Age (years)   Presenting symptom                              Immunohistochemical studies other than ER and PR                                                                                           ER, PR         HPV              FIGO stage   Treatment                                        Outcome
  -------------------------- ------------- ----------------------------------------------- ------------------------------------------------------------------------------------------------------------------------------------------ -------------- ---------------- ------------ ------------------------------------------------ ----------------------------
  Moll et al., 1990\         50            Postcoital vaginal bleeding, menometrorrhagia   NA                                                                                                                                         NA             NA               III          Sx, Rx                                           DOD 10 mo
  [@bib0010]                                                                                                                                                                                                                                                                                                                        

  Mayorga et al., 1997\                                                                                                                                                                                                                                                                                                             
  [@bib0015]                                                                                                                                                                                                                                                                                                                        

  Case 1                     68            Postcoital vaginal bleeding                     NA                                                                                                                                         NA             NA               Ib           NACT and Sx                                      Disease-free at 35 mo

  Case 2                     74            Postmenopausal bleeding                         NA                                                                                                                                         NA             NA               Ib           Sx                                               Disease-free at 35 mo

  Haswani et al., 1998\                                                                                                                                                                                                                                                                                                             
  [@bib0020]                                                                                                                                                                                                                                                                                                                        

  Case 1                     33            Asymptomatic (routine vaginal smear: AGC-NOS)   NA                                                                                                                                         ER: −          HPV type 18: +   III          Rx, Chemo                                        DOD 10 mo

  Case 2                     38            Postcoital vaginal bleeding                     NA                                                                                                                                         ER: −, PR: −   NA               Ib           Sx and Rx                                        Disease-free at 18 mo

  Cardosi et al., 1999\      53            Perimenopausal bleeding                         NA                                                                                                                                         ER: +, PR: +   NA               Ib           Sx, Rx, Chemo                                    Disease-free at 6 mo
  [@bib0025]                                                                                                                                                                                                                                                                                                                        

  Moritani et al., 2004\     29            AUB                                             Positive for CK, MUC5AC\                                                                                                                   ER: −, PR: −   −                III          Chemo                                            Disease-free at 6 mo
  [@bib0030]                                                                               Negative for vimentin, MUC2, MUC6                                                                                                                                                                                                        

  Suárez- et al., 2007\      80            Vaginal discharge                               Positive for CK AE1-AE3, CK 20, carcinoembryonic antigen, chromogranin A, synaptophysin\                                                   NA             NA               III          Rx, Chemo                                        DOD 18 mo
  [@bib0035]                                                                               Negative for vimentin, S-100 protein, HMB-45, adrenocorticotropic hormone, prolactin, thyroid-stimulating hormone, follicle-stimulating\                                                                                                 
                                                                                           hormone, luteinizing hormone, growth hormone, gross\                                                                                                                                                                                     
                                                                                           cystic disease fluid protein 15                                                                                                                                                                                                          

  Insabato et al., 2007\     46            AUB (cervical polypoid lesion)                                                                                                                                                             NA             NA               Ib           Sx, Rx, Chemo                                    Disease-free at 3 years
  [@bib0040]                                                                                                                                                                                                                                                                                                                        

  McCluggage et al., 2007\   NR            NR                                              Positive for CK 7 and CK 16\                                                                                                               NA             NR               NR           NR                                               NR
  [@bib0045]\                                                                              Negative for CK 20 and CDX2                                                                                                                                                                                                              
  (2 cases)                                                                                                                                                                                                                                                                                                                         

  Versas et al., 2009\                                                                                                                                                                                                                                                                                                              
  [@bib0050]                                                                                                                                                                                                                                                                                                                        

  Case 1                     36            Thromboembolic events                           Positive for p16 and CK 7\                                                                                                                 ER: −, PR: −   \+               IV           Chemo                                            Dod 7 weeks
                                                                                           Negative for CK 20, CDX2 and Dpc4                                                                                                                                                                                                        

  Case 2                     43            Metastases of lung and lymph nodes              Positive for p16 and CK 7\                                                                                                                 ER: −, PR: −   NA               IV           Chemo                                            Dod 2 mo
                                                                                           Negative for CK 20, CDX2 and mammoglobin                                                                                                                                                                                                 

  Lowery et al., 2009\       About 60      Postmenopausal bleeding                         NA                                                                                                                                         NA             NA               Ib1          Rx and Sx (for synchronous endometrial cancer)   Disease-free at \>10 years
  [@bib0055]                                                                                                                                                                                                                                                                                                                        

  Balci et al., 2010\        53            Postmenopausal bleeding                         Positive for CK, p16, CEA, MUC1, and MUC5.\                                                                                                ER: −, PR. −   HPV type 18: +   NR           Sx                                               NR
  [@bib0060]                                                                               Negative for CK 20, GCDFP15, MUC2, chromogranine, synaptophysin,\                                                                                                                                                                        
                                                                                           PGP 9.5, CD56, vimentin,\                                                                                                                                                                                                                
                                                                                           CDX-2, TTF-1, and mammaglobin                                                                                                                                                                                                            

  Yoon et al., 2011\         47            Postcoital vaginal bleeding                     Positive for p53 and Rb                                                                                                                    NA             NA               Ib1          Sx                                               Dod 6 mo
  [@bib0065]                                                                                                                                                                                                                                                                                                                        

  Giordano et al., 2012\     45            Persistent AUB                                  Positive for CK 7, CA-125, CEA and p16\                                                                                                    NA             HPV type 18: +   IIb          Sx                                               NR
  [@bib0070]                                                                               Negative for vimentin                                                                                                                                                                                                                    

  Washimi et al., 2015\      31            AUB                                             Positive for MUC2, CDX2, CEA, CK7\                                                                                                         ER: −, PR: −   HPV type 18: +   Ib1          Sx and chemo                                     Disease-free at 41 mo
  [@bib0005]                                                                               Negative for MUC1, MUC5AC, MUC6, p53, CK20, TTF-1, GCDFP-1, mammoglobin, chromogranin-1, p16, HIK1083                                                                                                                                    

  Present case               48            Postcoital vaginal bleeding                     Positive for p16, CDX-2, MUC1\                                                                                                             ER: −, PR: −   HPV type 18: +   Ib1          Sx                                               Disease-free at 18 mo
                                                                                           MUC2, MUC5AC\                                                                                                                                                                                                                            
                                                                                           Negative for synaptophysin, chromogranin A, CK20                                                                                                                                                                                         
  --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

CK: cytokeratin. MUC: mucin. TTF: thyroid transcripton factor. GCDFP: gross cystic disease fluid protein. ER: estrogen receptor. PR: progesteron receptor. NA: not available. Sx: surgery. Rx: radiation therapy. DOD: died of disease. Mo: months. NACT: neoadjuvant chemotherapy. Chemo: chemotherapy. AUB: abnormal uterine bleeding. NR: not reported.
